These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24494794)

  • 1. Ustekinumab for the treatment of psoriatic arthritis.
    Chandler DJ; Bewley A
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):111-21. PubMed ID: 24494794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ustekinumab associated with flares of psoriatic arthritis.
    Stamell EF; Kutner A; Viola K; Cohen SR
    JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis.
    Weitz JE; Ritchlin CT
    Expert Opin Biol Ther; 2014 Apr; 14(4):515-26. PubMed ID: 24555741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ustekinumab for resistant psoriatic arthritis.
    Wallis DE; Waldron NM; Korendowych E
    J Rheumatol; 2013 Feb; 40(2):207. PubMed ID: 23378500
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasis treated with ustekinumab in a patient with hepatitis C.
    Abuchar A; Vitiello M; Kerdel FA
    Int J Dermatol; 2013 Mar; 52(3):381-2. PubMed ID: 23414168
    [No Abstract]   [Full Text] [Related]  

  • 8. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
    Gordon KB; Ruderman EM
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ustekinumab: a review of its use in psoriatic arthritis.
    McKeage K
    Drugs; 2014 Jun; 74(9):1029-39. PubMed ID: 24919864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ustekinumab for psoriasis and psoriatic arthritis.
    Goldminz AM; Gottlieb AB
    J Rheumatol Suppl; 2012 Jul; 89():86-9. PubMed ID: 22751602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ustekinumab for psoriatic arthritis.
    Cuchacovich RS; Espinoza LR
    Lancet; 2009 Feb; 373(9664):605-6. PubMed ID: 19217153
    [No Abstract]   [Full Text] [Related]  

  • 13. Ustekinumab for the treatment of psoriatic arthritis.
    Wofford J; Menter A
    Expert Rev Clin Immunol; 2014 Feb; 10(2):189-202. PubMed ID: 24410536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
    Gottlieb A; Korman NJ; Gordon KB; Feldman SR; Lebwohl M; Koo JY; Van Voorhees AS; Elmets CA; Leonardi CL; Beutner KR; Bhushan R; Menter A
    J Am Acad Dermatol; 2008 May; 58(5):851-64. PubMed ID: 18423261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriatic arthritis.
    Gladman DD
    Dermatol Ther; 2009; 22(1):40-55. PubMed ID: 19222516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial.
    Kavanaugh A; Menter A; Mendelsohn A; Shen YK; Lee S; Gottlieb AB
    Curr Med Res Opin; 2010 Oct; 26(10):2385-92. PubMed ID: 20831455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How effective is ustekinumab in controlling psoriatic arthritis?
    Bonifati C; Graceffa D
    Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
    Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
    Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.
    Garcia-Valladares I; Cuchacovich R; Espinoza LR
    Drug Des Devel Ther; 2011 Jan; 5():41-9. PubMed ID: 21267358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.